"get'r done Leo". Some mistakenly believe this year has gone by the wayside. Far from it.
Kevetrin has been advanced and is still on the burner.
Toxicology studies for the oral formulation of Kevetrin are approximately half completed, with the remainder of this work now prioritized given the Company has secured additional financial resources. Next steps in the development of Kevetrin include: completing toxicology work for an oral formulation; developing the oral formulation (pill or tablet); requesting an FDA meeting to discuss trial results to date and the design of future trials; and performing a dosing safety study in healthy volunteers once the oral formulation has been developed. Once completed, these steps would likely lead directly to Phase 2 testing of oral Kevetrin in both solid tumors and leukemias, with ovarian cancer likely continuing to be the lead indication.
Brilacidin data has been compiled and now setting up for the EOP Meeting. Don't forget how much effort it takes to put this stuff together.
I know I'm with many on the disappointment of the cost overruns for the prurisol trial and not being in the position to dwindle down enough to pay for them. But it seems Leo has a plan.
IMO, we're looking at the next 12 months in the wrong way. Half empty. But, the market is typically reactionary and won't give IPIX a green light until the partnership comes through and we see the green on the table to move these trials without the extreme dilution it would take to go it alone. A lot can happen. And it can happen overnight. This has been completely risk/reward based for quite some time if not from the beginning. Remember the statements that have been made about being de-risked because the science has met so many expectations and no trials failures to date?
We're pretty much on the same page kfc, I've been messing with bio's for some time now. Knowing it takes time is one thing, watching the flags and what yard line we're on and knowing your tolerance level is key.
It's Leo's ball and Dr' B is also one of our major players.
Get'r done!!
$IPIX
News 
Market Data 
Discover 
AI
